Inspirata Unveils New Partnership at the Association of Pathology Chairs (APC) Annual Meeting 2022

Digital pathology and cancer informatics provider Inspirata is proud to announce a new partnership with precision pathology company SpIntellx, further strengthening and diversifying Inspirata’s growing partner ecosystem.

This partnership allows Inspirata and SpIntellx customers the seamless integration of Dynamyx and HistoMapr-Breast, resulting in a more efficient breast core-biopsy workflow with access to unbiased and advanced spatial analytics powered by explainable AI (xAI). The integration of these user interfaces will provide pathologists total autonomy and control over their case workload.

“We are excited to partner with SpIntellx to bring new translational research and clinical spatial analysis tools to the Dynamyx digital pathology platform,” said Mark Lloyd, Founder and Executive Vice President of Inspirata. “The spatial and functional relationships between cells are central to precision pathology. Building translational research tools into the Dynamyx workflow helps to facilitate the adoption of digital pathology.”

“Explainable AI is a vital feature in building trust and transparency between pathology disease experts and computational pathology systems, and it is also a departure from more traditional black-box AI approaches to digital pathology such as deep learning,” stated SpIntellx co-founder and CTO, S. Chakra Chennubhotla, PhD. “As machine learning accelerates in medicine, improved communication between humans and their machine learning tools is critical.”

Inspirata, located at Booth #18, will exhibit at the Association of Pathology Chairs (APC) Annual Meeting in Chicago from July 17^th – 20^th. At the event, Inspirata will showcase the latest capabilities of Dynamyx release 2.5.0 and be available to discuss this exciting partnership with SpIntellx.